Earlier this week Congresswoman Gwen Moore became a cosponsor of The Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2015 (HR 2311).
Updates about what is happening on the legislative and regulatory level – news events that affect your digestive health.
Launched by the President in his State of the Union Address, the Precision Medicine Initiative seeks to pioneer a new model of medicine and research that veers away from the "one-size-fits-all" approach and takes into account individual differences when treating disease.
On June 29, 2015, William Norton presented the following Public Docket comments on behalf of IFFGD members in regard to the FDA Patient-Focused Drug Development public meeting on Functional GI Disorders:
On behalf of the International Foundation for Functional Gastrointestinal Disorders (IFFGD) I appreciate this opportunity to offer additional comments, including the attached reports, regarding the Functional GI Disorders Patient-Focused Drug Development Public Meeting held on May 11, 2015.
Today Representative Gwen Moore (WI-4) made an official statement to the US House of Representatives in support of National recognition of Gastroparesis Awareness Month in August and urged her Congressional colleagues to support increased research to improve treatments for those affected:
IN HONOR OF NATIONAL GASTROPARESIS AWARENESS MONTH
HON. GWEN MOORE
Last week The Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2015 (HR 2311) gained another cosponsor. California Representative Zoe Lofgren, who represents the state's 19th district covering most of San Jose, signed on to support this legislation in the House of Representatives. If you live in California's 19th Congressional district, please consider taking a moment to thank Representative Lofgren for supporting functional GI and motility disorders research!
On July 21st we will join together to raise critical awareness for all those suffering with a functional gastrointestinal (GI) or motility disorder by asking our Members of Congress to cosponsor the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2015 (HR 2311), a piece of revenue-neutral legislation that seeks to advance scientific understanding of these conditions by encouraging and bolstering research.
Late last week Representative F. James Sensenbrenner, Jr. (WI-5) circulated the following Dear Colleague letter to invite other House Members of Congress to cosponsor The Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2015 (HR 2311):
SUPPORT H.R. 2311, THE FUNCTIONAL GASTROINTESTINAL AND MOTILITY DISORDERS RESEARCH ENHANCEMENT ACT
After hearing from his constituents, Indiana's André Carson is the first to cosponsor the recently reintroduced Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2015 (HR 2311). Congressman Carson represents the 7th Congressional district in the heart of Indiana. If you live in Indiana's 7th Congressional district, please consider taking a moment to thank Representative Carson for supporting functional GI and motility disorders research!
Last month, the US House Energy and Commerce Committee unanimously approved a medical cures bill after reaching a bipartisan funding deal for the legislation. This bill, called the 21st Century Cures Act (HR 6), seeks to narrow the gap between the scientific development of medical therapies and the way that these therapies are regulated in the US.